• English
  • Eesti
    NewsNews

    The Estonian medicinal products market in fourth quarter 2019

    14.02.2020
    Printer-friendly version

    Estonian drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. The statistics of veterinary medicinal products includes sales to general and veterinary pharmacies, veterinarians and to other institutions. The medicinal products market is expressed in wholesale prices which includes the price of the manufacturer and wholesaler’s mark-up and does not include the VAT.

    Human medicines

    In the fourth quarter of 2019 the medicinal products market increased 4.5% reaching to 92.7 million euros. Estonian human medicines market of previous five years shows also an increasing trend:


    Figure 1. Estonian human medicines market in fourth quarter 2015–2019

    Sales to general pharmacies were 67.3 million euros, sales to hospital pharmacies 24.6 million euros and sales to other institutions 0.8 million euros.

    Prescription sales covered most of the medicinal products market, being 79.8 million euros. The turnovers of over the counter sales and hospital package sales were 12.3 million euros and 0.5 million euros.

    Based on ATC classification, the most sold medicines by turnover, were antineoplastic and immunomodulating agents (19.8 million euros), alimentary tract and metabolism medicines (11.5 million euros) and blood and blood forming organs drugs (11.2 million euros).

    Defined Daily Dose (DDD) is the assumed average dose per day for the drug used in its main indication in adults. Defined Daily Dose per thousand inhabitants a day (DDD/1000/day) expresses the proportion of the population within a defined area treated daily with certain drugs.

    According to DDD/1000/day the most consumed medicines in the fourth quarter of 2019 were cardiovascular system drugs (480 DDD/1000/day), alimentary tract and metabolism drugs (200 DDD/1000/day) and nervous system medicines (146 DDD/1000/day).

    In the fourth quarter of 2019, almost 3700 different medicinal preparation packages and 1200 active substances were marketed in Estonia.

    Veterinary medicines

    In the fourth quarter of 2019 the Estonian veterinary medicinal products market remained at the same level compared to the same period in 2018 reaching to 3.36 million euros.

    The most sold medicines by turnover were antiinfectives for systemic use (0.8 million euros), followed by immunologicals (0.7 million euros) and antiparasitic products (0.5 million euros).

    91% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 6% to the veterinary pharmacies, 3% to the general pharmacies and 0.05% to other institutions (generally state- and scientific institutions).


    Figure 2. Estonian veterinary medicines market in fourth quarter 2015–2019